Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Dose-finding Study to Evaluate the Pharmacodynamic (PD) Profiles and Efficacy of Different Dosing Regimens of Leuprolide Oral Tablets (Ovarest®) in Women With Endometriosis

NCT05096065 is registered in ClinicalTrials.gov with Enteris BioPharma Inc. as lead sponsor.

NCT NCT05096065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05096065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Dose-finding Study to Evaluate the Pharmacodynamic (PD) Profiles and Efficacy of Different Dosing Regimens of Leuprolide Oral Tablets (Ovarest®) in Women With Endometriosis
Lead sponsor
Enteris BioPharma Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
March 18, 2022
Completion date
May 31, 2022
Enrollment
16 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis